George C. Prendergast | |
|---|---|
 | |
| Born | Philadelphia, Pennsylvania |
| Alma mater | Princeton University Yale University University of Pennsylvania |
| Awards | 1995 Pew Scholar in the Biomedical Sciences |
| Scientific career | |
| Fields | Oncology, Molecular biology, Oncoimmunology |
| Institutions | Lankenau Institute for Medical Research DuPont Pharmaceuticals Company The Wistar Institute Merck Research Laboratories Howard Hughes Medical Institute |
George C. Prendergast (born 1961) is an American biomedical scientist. His research has focused on cancer pathobiology and immunology.[1] Since 2004, he has been the president and CEO of Lankenau Institute for Medical Research, a cancer-focused research center in the U.S.[2][3][4] He is also the co-director of the Program in Cancer Cell Biology & Signaling at the Sidney Kimmel Cancer Center, Thomas Jefferson University.[5]
- ^ "George C. Prendergast - Science History". sciencehistory.org. Retrieved 12 November 2008.
- ^ "Lankenau Institute for Medical Research - George C. Prendergast, PhD". Retrieved 29 December 2013.
- ^ "Lankenau Institute for Medical Research: History and Accomplishments".
- ^ "Low-carbohydrate, high-protein diets may reduce both tumor growth rates and cancer risk". sciencedaily.com. Retrieved 15 June 2011.
- ^ Program in Cancer Cell Biology & Signaling, Kimmel Cancer Center, Thomas Jefferson University